PAOG Publishes 2021 Cannabis Biopharmaceutical Strategic Outlook
Sandusky, OH, January 14, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today published a management outlook for 2021 on the company’s strategy to develop and monetize the cannabis assets acquired last year. The strategic outlook is included in its entirety below: PAOG 2021 Cannabis Biopharmaceutical Strategic Outlook PAOG is
PAOG Confirms Cannabis Biopharmaceutical Strategic Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2021
Sandusky, OH, January 12, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today confirmed an update covering the company’s 2021 cannabis pharmaceutical and nutraceutical development outlook is scheduled this Thursday Jan 14th, 2021. In 2020, PAOG acquired a hemp cultivation business from Puration, Inc. (OTC PINK: PURA) and RespRx from Kali-Extracts,
Nutra Pharma Letter to Shareholders
Plantation, Florida, January 12, 2021 — OTC PR WIRE — Nutra Pharma Corporation (OTC PINK: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, announced today that the Company’s
PAOG Cannabis Pharmaceutical and Nutraceutical 2021 Strategy Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2021
Sandusky, OH – January 11, 2021 – PAO Group, Inc. (OTC PINK: PAOG) today announced an update covering the company’s 2021 cannabis pharmaceutical and nutraceutical development outlook is scheduled this Thursday Jan 14th, 2021. In 2020, PAOG acquired a hemp cultivation business from Puration, Inc. (OTC PINK: PURA) and RespRx from Kali-Extracts, Inc. (OTC
PAOG Confirms Q4 2020 Revenue From Cannabis Asset Acquisition
Sandusky, OH, January 8, 2021 – OTC PR WIRE — PAO Group, Inc. (OTC PINK: PAOG) today confirmed that the company expects to realize and report in Q4 2020 the first revenue from assets acquired in the course of 2020. In 2020, PAOG acquired a hemp cultivation business from Puration, Inc. (OTC PINK: PURA)
DGDM Developing Sales and Distribution Channels Ahead of the Much-Anticipated EPA Approval of MiteXstream(TM), Its Proven Disruptive Pesticide Product Targeted to MJ Growers
FLOWER MOUND, TX, December 16, 2020 – OTC PR WIRE – Digital Development Partners, Inc. (OTC PINK: DGDM) (“DGDM” or the “Company”), doing business as Black Bird Potentials Inc., the exclusive distributor of MiteXstream biopesticide and manufacturer of Grizzly Creek Naturals CBD products (https://grizzlycreeknaturals.com/), ahead of next week’s expected EPA approval of MiteXstream, has begun
12 Nov
PAOG Building CBD Pharma Capacity In Partnership With PURA – Partnership Includes PAOG Stock Dividend To PURA Shareholders
Sandusky, Ohio – November 12, 2020 – OTC PR WIRE – PAO Group, Inc. (OTC PINK: PAOG) today confirmed a pharmaceutical and neurocritical extraction partnership with Puration, Inc. (OTC PINK: PURA). PURA has acquired a 72-acre property in Farmersville, Texas as the foundation of an innovative, hemp processing plant. PURA is building partnerships to participate
03 Nov
Nutra Pharma Provides Business and Compliance Updates
Nutra Pharma is providing updates regarding their business plans, accounting and compliance Plantation, Florida, November 3, 2020 — OTC PR WIRE — Nutra Pharma Corporation (OTC PINK: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis
Contact Us
- 707-OTC-WIRE (707-682-9473)
- cs@otcprwire.com
Recent Comments